Inluriyo

Active Ingredient(s): Imlunestrant
FDA Approved: * September 25, 2025
Pharm Company: * ELI LILLY CO
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Inluriyo 200 mg Oral Tablet, Film Coated
NDC: 0002-1717
Labeler:
Eli Lilly and Company